12 patents
Utility
Concentrated Liquid Pharmaceutical Formulations of Furosemide and Methods of Administering the Same
7 Sep 23
Disclosed herein, in part, are liquid pharmaceutical formulations comprising furosemide or a pharmaceutically acceptable salt thereof, one or more pharmaceutically acceptable excipients, and a pharmaceutically acceptable buffer.
Alfredo Grossi, Britt Kostraba, Olatokumbo Olajimi Luca Ogunleye, Shannon Terry, Franciscus Koppenhagen
Filed: 5 Jan 23
Utility
Methods of Treatment Using Furosemide
31 Aug 23
Disclosed herein, in part, are methods of subcutaneously administering liquid pharmaceutical formulations of furosemide to an adult patient from a prefilled cartridge using a five-hour bi-phasic delivery profile.
John F. Mohr, III, John Tucker, Michael Hassman, Erik Mark Pecorelli
Filed: 5 Aug 21
Utility
Pharmaceutical Formulations for Subcutaneous Administration of Furosemide
29 Jun 23
The present teachings relate to liquid pharmaceutical formulations of furosemide, where the pharmaceutical formulations include a molar excess of tris(hydroxymethyl)aminomethane to furosemide, have a pH in the range of 7 to 8.5, and a concentration of tris(hydroxymethyl)aminomethane greater than or equal to about 50 mM.
Scott A. Michaels, Pieter Muntendam, Glenn R. Larsen
Filed: 5 Aug 22
Utility
Concentrated liquid pharmaceutical formulations of furosemide
7 Feb 23
Disclosed herein, in part, are liquid pharmaceutical formulations comprising furosemide or a pharmaceutically acceptable salt thereof, one or more pharmaceutically acceptable excipients, and a pharmaceutically acceptable buffer.
Alfredo Grossi, Britt Kostraba, Olatokumbo O. Luca Ogunleye, Shannon Terry, Franciscus Koppenhagen
Filed: 2 Aug 22
Utility
Concentrated liquid pharmaceutical formulations of furosemide
24 Jan 23
Disclosed herein, in part, are liquid pharmaceutical formulations comprising furosemide or a pharmaceutically acceptable salt thereof, one or more pharmaceutically acceptable excipients, and a pharmaceutically acceptable buffer.
Alfredo Grossi, Britt Kostraba, Olatokumbo O. Luca Ogunleye, Shannon Terry, Franciscus Koppenhagen
Filed: 5 Aug 22
Utility
Concentrated Liquid Pharmaceutical Formulations of Furosemide
1 Dec 22
Disclosed herein, in part, are liquid pharmaceutical formulations comprising furosemide or a pharmaceutically acceptable salt thereof, one or more pharmaceutically acceptable excipients, and a pharmaceutically acceptable buffer.
Alfredo Grossi, Britt Kostraba, Olatokumbo O. Luca Ogunleye, Shannon Terry, Franciscus Koppenhagen
Filed: 5 Aug 22
Utility
Concentrated Liquid Pharmaceutical Formulations of Furosemide
1 Dec 22
Disclosed herein, in part, are liquid pharmaceutical formulations comprising furosemide or a pharmaceutically acceptable salt thereof, one or more pharmaceutically acceptable excipients, and a pharmaceutically acceptable buffer.
Alfredo Grossi, Britt Kostraba, Olatokumbo O. Luca Ogunleye, Shannon Terry, Franciscus Koppenhagen
Filed: 2 Aug 22
Utility
Concentrated liquid pharmaceutical formulations of furosemide
15 Nov 22
Disclosed herein, in part, are liquid pharmaceutical formulations comprising furosemide or a pharmaceutically acceptable salt thereof, one or more pharmaceutically acceptable excipients, and a pharmaceutically acceptable buffer.
Alfredo Grossi, Britt Kostraba, Olatokumbo O. Luca Ogunleye, Shannon Terry, Franciscus Koppenhagen
Filed: 18 Feb 22
Utility
Pharmaceutical formulations for subcutaneous administration of furosemide
6 Sep 22
The present teachings relate to liquid pharmaceutical formulations of furosemide, where the pharmaceutical formulations include a molar excess of tris(hydroxymethyl)aminomethane to furosemide, have a pH in the range of 7 to 8.5, and a concentration of tris(hydroxymethyl)aminomethane greater than or equal to about 50 mM.
Scott A. Michaels, Pieter Muntendam, Glenn R. Larsen
Filed: 7 Mar 19
Utility
Concentrated Liquid Pharmaceutical Formulations of Furosemide
2 Jun 22
Disclosed herein, in part, are liquid pharmaceutical formulations comprising furosemide or a pharmaceutically acceptable salt thereof, one or more pharmaceutically acceptable excipients, and a pharmaceutically acceptable buffer.
Alfredo Grossi, Britt Kostraba, Olatokumbo O. Luca Ogunleye, Shannon Terry, Franciscus Koppenhagen
Filed: 18 Feb 22
Utility
Concentrated Liquid Pharmaceutical Formulations of Furosemide and Methods of Administering the Same
31 Mar 22
Disclosed herein, in part, are liquid pharmaceutical formulations comprising furosemide or a pharmaceutically acceptable salt thereof, one or more pharmaceutically acceptable excipients, and a pharmaceutically acceptable buffer.
Alfredo Grossi, Britt Kostraba, Olatokumbo O. Luca Ogunleye, Shannon Terry, Franciscus Koppenhagen
Filed: 30 Jan 20
Utility
Pharmaceutical Formulations for Subcutaneous Administration of Furosemide
5 Feb 20
The present teachings relate to liquid pharmaceutical formulations of furosemide, where the pharmaceutical formulations include a molar excess of tris(hydroxymethyl)aminomethane to furosemide, have a pH in the range of 7 to 8.5, and a concentration of tris(hydroxymethyl)aminomethane greater than or equal to about 50 mM.
Scott A. Michaels, Pieter Muntendam, Glenn R. Larsen
Filed: 6 Mar 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first